Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase II study of daily carboplatin plus irradiation followed by durvalumab therapy for older adults (≥75 years) with unresectable III non-small-cell lung cancer and performance status of 2: NEJ039A.
Mouri A, Kisohara A, Morita R, Ko R, Nakagawa T, Makiguchi T, Isobe K, Ishikawa N, Kondo T, Akiyama M, Bessho A, Honda R, Yoshimura K, Kagamu H, Kato S, Kobayashi K, Kaira K, Maemondo M. Mouri A, et al. Among authors: bessho a. ESMO Open. 2024 Oct;9(10):103939. doi: 10.1016/j.esmoop.2024.103939. Epub 2024 Oct 11. ESMO Open. 2024. PMID: 39395258 Free PMC article. Clinical Trial.
Gefitinib induction followed by chemoradiotherapy in EGFR-mutant, locally advanced non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study.
Hotta K, Saeki S, Yamaguchi M, Harada D, Bessho A, Tanaka K, Inoue K, Gemba K, Shiojiri M, Kato Y, Ninomiya T, Kubo T, Kishimoto J, Shioyama Y, Katsui K, Sasaki J, Kiura K, Sugio K. Hotta K, et al. Among authors: bessho a. ESMO Open. 2021 Aug;6(4):100191. doi: 10.1016/j.esmoop.2021.100191. Epub 2021 Jun 18. ESMO Open. 2021. PMID: 34153652 Free PMC article. Clinical Trial.
Corrigendum to 'Gefitinib induction followed by chemoradiotherapy in EGFR-mutant, locally advanced non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study': [ESMO Open Volume 6, Issue 4, August 2021, 100191].
Hotta K, Saeki S, Yamaguchi M, Harada D, Bessho A, Tanaka K, Inoue K, Gemba K, Shiojiri M, Kato Y, Ninomiya T, Kubo T, Kishimoto J, Shioyama Y, Katsui K, Sasaki J, Kiura K, Sugio K. Hotta K, et al. Among authors: bessho a. ESMO Open. 2022 Aug;7(4):100532. doi: 10.1016/j.esmoop.2022.100532. Epub 2022 Jul 6. ESMO Open. 2022. PMID: 35802950 Free PMC article. No abstract available.
[Chemotherapy for small-cell lung cancer].
Ueoka H, Kiura K, Tabata M, Bessho A, Matsushita A, Chikamori K, Yamane H, Harada M, Kimura I, Ohnoshi T. Ueoka H, et al. Among authors: bessho a. Nihon Kyobu Shikkan Gakkai Zasshi. 1996 Dec;34 Suppl:87-91. Nihon Kyobu Shikkan Gakkai Zasshi. 1996. PMID: 9216192 Review. Japanese.
Phase I/II study of docetaxel and cisplatin with concurrent thoracic radiation therapy for locally advanced non-small-cell lung cancer.
Kiura K, Ueoka H, Segawa Y, Tabata M, Kamei H, Takigawa N, Hiraki S, Watanabe Y, Bessho A, Eguchi K, Okimoto N, Harita S, Takemoto M, Hiraki Y, Harada M, Tanimoto M; Okayama Lung Cancer Study Group. Kiura K, et al. Among authors: bessho a. Br J Cancer. 2003 Sep 1;89(5):795-802. doi: 10.1038/sj.bjc.6601217. Br J Cancer. 2003. PMID: 12942107 Free PMC article. Clinical Trial.
Small cell lung cancer can express CD34 antigen.
Yamane H, Kiura K, Tabata M, Bessho A, Tsuchida T, Motoda K, Hiraki A, Ueoka H, Harada M. Yamane H, et al. Among authors: bessho a. Anticancer Res. 1997 Sep-Oct;17(5A):3627-32. Anticancer Res. 1997. PMID: 9413215
86 results